Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Genesis Pharma And Deciphera Pharmaceuticals Have Announced An Exclusive Distribution Agreement For Ripretinib In 14 European Markets In Central And Eastern Europe For The Commercialization Of Ripretinib For Fourth-line Gastrointestinal Stromal Tumor

Author: Benzinga Newsdesk | January 12, 2024 07:39am

Posted In: DCPH